PPT-Immunologically high-risk kidney

transplantation the role of desensitization protocols Milica Kravljaca Clinic of Nephrology University Clinical Center of Serbia Faculty of Medicine University of Belgrade What are the key challenges in kidney transplantation today. Nutrition Intervention. Identify chronic kidney disease (CKD). . Identify common co-morbidities and interventions to slow CKD progression. . Associate CKD complications with lab data, nutrition interventions and basic medications. . Liz Leen. Patient. Enez. Joaquin . 24 y/o Pima Indian . Diagnosed with T2DM at age 13. Has not been compliant with prescribed . . treatment. Progressive decompensation of . kidney function over past 7 years . for Type 2 Diabetes. 1. AACE Outpatient Glucose Targets for Nonpregnant Adults. Parameter. Treatment Goal. A1C, %. Individualize on the basis of age, comorbidities,. . duration of disease, and hypoglycemia. Epidemiology. CKD affects about 26 million people in the US. Approximately 19 million adults are in the early stages of the disease . On the rise do to increasing prevalence of diabetes and hypertension. Epidemiology. CKD affects about 26 million people in the US. Approximately 19 million adults are in the early stages of the disease . On the rise do to increasing prevalence of diabetes and hypertension. Disease. NGAL and Cystatin C. COL SOHAIL SABIR. HOD NEPHROLOGY MILITARY HOSPITAL. HOD MEDICAL EDUCATION . ARMED . FORCES POSTGRADUATE MEDICAL INSTITUTE. Biomarker. characteristic . that is objectively measured and evaluated as an indicator of normal biological or pathogenic processes, or pharmacologic responses to a therapeutic intervention. Pai. , . PharmD. , BCPS, FASN, FCCP. Counseling High-Risk Patients on NSAID Use to Prevent Kidney Injury. Understand how prescription and non-prescription drugs affect blood flow through the kidneys (hemodynamics). Namita Singh, MD, FASN. Year 2021. DISCLOSURES. I have no financial relationships with commercial interests to disclose.. This presentation does not include discussion of off-label or investigational use. . WHAT IS ACUTE KIDNEY INJURY(AKI) ?. An abrupt . decline in renal . function defined by:. An increase . in serum creatinine > 26.5 umol/l within 48hours or . > . 1.9 times baseline . known or presumed in the last . 1. KFRE Description. KFRE is a well validated risk prediction tool for kidney replacement therapy (KRT, the need for dialysis or a kidney transplant), in the next two or five years for adults with chronic kidney disease (CKD) Stages 3A to 5 (eGFR <60 ml/min/1.73m. Featured Clinical Research – Late Breaking Clinical Trials . Residual Inflammatory Risk and Residual Cholesterol Risk Among Statin Treated Atherosclerosis Patients With and Without Chronic Kidney Disease:. 1 2 socioeconomic status and reporting of data19-22. The standardized incidence rate for kidney cancer is 12.6 and 3.4 per 100,000 per year in men in developed and non-developed regions, respectively. Day?. Worldwide . campaign. . celebrated. . every. . year. on the second Thursday of March . [12 March 2015]. A joint . partnership. . between. the International Society of . Nephrology. (ISN) and the International . Tracy Anderson-Haag, . PharmD. , BCPS. Clinical Pharmacy Specialist. Hennepin Healthcare. and. Clinical Assistant Professor. University of Minnesota, College of Pharmacy. Objectives. Describe recent changes to medication labeling, guidelines and practice patterns for use of controversial medications in patients with chronic kidney disease.